‘Ozempic Face’ Seen Driving Botox Sales, AbbVie Says
The loss of facial fat can lead to looser-looking skin, and that’s given rise to the term “Ozempic face” on social media.
Photographer: Peter Cade/Stone RFThis article is for subscribers only.
AbbVie Inc. sees “Ozempic face” — the saggy, hollowed out look some patients report after taking weight-loss drugs — as a potential boon for Botox sales.
“The majority of people who engage in these medical weight-loss products are more interested in aesthetics afterwards,” Carrie Strom, the president of the AbbVie division that sells Botox, said on an earnings call Friday. “We do see it as a long-term tailwind.”